HLA antibody testing part 2

HLA antibodies

 

A major stimulant of allograft rejection is recipient T cell recognition of human leucocyte antigens  in the donor kidney. Preforemed  donor-specific HLA antibodies resulting in hyperacute rejection were first detected in 1969 by the complement-dependent cytotoxicity crossmatch assay; widespread application of this test detected higher titer donor-specific antibodies and reduced hyperacute  and early accelerated rejection episodes. Evolution to flow cytometry cross-matching offers improved sensitivity for low titer but nonetheless, pathogenic antibodies. Newer immunoassays (using ELISA plates or microsphere technology), where purified HLA antigens are covalently bound to a solid-phase platform, have further improved sensitivity and specifity of HLA antibody detection. Despite advancements in technology, newer solid-phase assays have a number of interpretive considerations that must be appreciated by clinicians in order to more appropriately apply test results to patient care.

Advertisements

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s